This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2025
Title: Anita Boyapati: Innovator in Rheumatoid Arthritis Treatment
Introduction
Anita Boyapati is a prominent inventor based in Chappaqua, NY (US). She has made significant contributions to the field of medical research, particularly in the treatment of rheumatoid arthritis. With a total of 2 patents, her work has the potential to improve the lives of many individuals suffering from this chronic condition.
Latest Patents
Anita's latest patents include a method of diagnosis and treatment of rheumatoid arthritis. This patent focuses on the use of an anti-IL6 receptor antibody for treating rheumatoid arthritis in subjects with specific serum concentrations of biomarkers. Another notable patent is related to methods and compositions for treating subjects with rheumatoid arthritis using a human anti-interleukin 6 (IL-6) antibody or its antigen-binding portion. These innovations highlight her dedication to advancing medical treatments.
Career Highlights
Throughout her career, Anita has worked with leading companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. and Sanofi Biotechnology. Her experience in these organizations has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her expertise in the field.
Collaborations
Anita has had the opportunity to work alongside talented individuals such as Jérôme Msihid and Neil John Graham. These collaborations have contributed to her success and the development of her innovative patents.
Conclusion
Anita Boyapati is a remarkable inventor whose work in rheumatoid arthritis treatment is paving the way for new therapeutic approaches. Her patents and career achievements reflect her commitment to improving patient outcomes in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile